Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04945798 · ClinicalTrials.gov registry record · NA

Effects of Osteopathic Manipulative Treatment of Fascial Restrictions on Body Awareness, Mood, and Proprioception

A NA study of Segmental and Somatic Dysfunction of Other Regions (M99.09), sponsored by New York Institute of Technology.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT04945798: Completed NA study of Segmental and Somatic Dysfunction of Other Regions (M99.09), sponsored by New York Institute of Technology.

NCT04945798 is a NA study of Segmental and Somatic Dysfunction of Other Regions (M99.09) that has completed, run by New York Institute of Technology. The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04945798, a NA study of Segmental and Somatic Dysfunction of Other Regions (M99.09), has completed, sponsored by New York Institute of Technology.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to assess the effects osteopathic manipulative treatment (OMT) of fascial strain patterns on body awareness, proprioception, and mood.

Interventions

  • OTHER OMT

Study Locations (1)

Arkansas

  • New York Institute of Technology College of Osteopathic Medicine at Arkansas State University - Jonesboro

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2021-03-22
Est. Completion 2022-03-15
Phase NA

Sponsor

New York Institute of Technology

49 total trials

What the Registry Record Tells You About NCT04945798

The ClinicalTrials.gov registry entry for NCT04945798 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York Institute of Technology, which has 49 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Segmental and Somatic Dysfunction of Other Regions (M99.09) appearing as the primary indexed condition, and to 1 intervention - of which OMT is the first listed.

NCT04945798 reports 1 study location spanning 1 distinct geographic area - top geographies include Arkansas.

Frequently Asked Questions

What is clinical trial NCT04945798 about?

NCT04945798 is a clinical study titled "Effects of Osteopathic Manipulative Treatment of Fascial Restrictions on Body Awareness, Mood, and Proprioception". The purpose of this research is to assess the effects osteopathic manipulative treatment (OMT) of fascial strain patterns on body awareness, proprioception, and mood.

What is the current status of trial NCT04945798?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2021-03-22. Estimated completion is 2022-03-15.

What conditions does trial NCT04945798 study?

This clinical trial studies the following conditions: Segmental and Somatic Dysfunction of Other Regions (M99.09).

What interventions are being tested in trial NCT04945798?

The interventions under investigation include: OMT (OTHER).

Who is sponsoring clinical trial NCT04945798?

This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04945798 being conducted?

This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.